Repeated Measurement of FIB-4 to Predict Long-Term Risk of HCC Development Up to 10 Years After SVR
Yanzheng Zou(Jiangsu University), Peng Huang(Zhuzhou Central Hospital), Sheng Yang(Nanjing Medical University), Ming Yue(Jiangsu Province Hospital), Yifan Wang(Io Therapeutics (United States)), Meiling Zhang(Zhejiang Cancer Hospital), Hongbo Chen(Jiangsu University), Yidi Wang(Zhongshan People's Hospital), Yue Feng(Kunming University of Science and Technology), Rongbin Yu(Nanjing Medical University), Linna Jia(Nanjing Medical University)
Cited by 9
Related Papers
RING domain–deficient BRCA1 promotes PARP inhibitor and platinum resistance
|Journal of Clinical Investigation|2016|107
Clinical characteristics of COVID-19 patients with clinically diagnosed bacterial co-infection: A multi-center study
|PLoS ONE|2021|68
Spectrum and Clinical Characteristics of Symptomatic and Asymptomatic Coronavirus Disease 2019 (COVID-19) With and Without Pneumonia
|Frontiers in Medicine|2021|63
Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID‐19 patients: Multicenter retrospective study
|Journal of Medical Virology|2020|30
<p>Adipose-Derived Stem Cells Promote Proliferation and Invasion in Cervical Cancer by Targeting the HGF/c-MET Pathway</p>
|Cancer Management and Research|2020|19